NovaBay Pharmaceuticals, Inc. Non-operating Income/Expense

Non-operating Income/Expense of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-operating Income/Expense growth rates and interactive chart. Income or expense that is usually non-recurring and not tied to a company's operations. It is stated separately on the income statement to differentiate it from operating expenses.


Highlights and Quick Summary

  • Non-operating Income/Expense for the quarter ending September 30, 2022 was $-663 Thousand (a 22000.0% increase compared to previous quarter)
  • Year-over-year quarterly Non-operating Income/Expense decreased by -84.91%
  • Annual Non-operating Income/Expense for 2021 was $-4.39 Million (a -202.33% decrease from previous year)
  • Annual Non-operating Income/Expense for 2020 was $4.29 Million (a -408.55% decrease from previous year)
  • Annual Non-operating Income/Expense for 2019 was $-1.39 Million (a 7.66% increase from previous year)
  • Twelve month Non-operating Income/Expense ending September 30, 2022 was $-7.34 Million (a 5.2% increase compared to previous quarter)
  • Twelve month trailing Non-operating Income/Expense increased by 56.68% year-over-year
Trailing Non-operating Income/Expense for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-7.34 Million $-6.98 Million $-6.97 Million $-4.68 Million
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-operating Income/Expense of NovaBay Pharmaceuticals, Inc.

Most recent Non-operating Income/Expenseof NBY including historical data for past 10 years.

Interactive Chart of Non-operating Income/Expense of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-0.66 $-0.0 $-2.28
2021 $-4.39 $-0.3 $0.0 $-4.39
2020 $0.01 $-1.16 $-3.41 $-0.05 $4.29
2019 $-0.45 $1.43 $-1.12 $-0.12 $-1.39
2018 $0.35 $0.27 $0.5 $0.22 $-1.29
2017 $0.4 $-0.28 $0.02 $-0.23 $0.11
2016 $0.38 $-1.68 $-0.45 $-0.43 $-2.17
2015 $2.06 $0.11 $-0.02 $0.02 $2.17
2014 $0.45 $-0.11 $0.85 $0.51 $1.71
2013 $0.72 $-0.86 $0.11 $-0.52 $-0.55
2012 $0.48 $0.19 $0.66 $-0.04 $1.28
2011 $-1.18 $-0.76

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology